Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Amylase concentration linked to mortality in guinea pigs
Researchers say the digestive enzyme is often overlooked.
Guinea pigs with high plasma concentrations of amylase face increased mortality.

Researchers have revealed the clinical significance of plasma amylase to the lifespan of guinea pigs.

The new study has found that guinea pigs which recorded particularly high plasma concentrations of amylase were more likely to die within 30 days of biochemistry analysis.

To investigate the causes of mortality in guinea pigs, researchers retrospectively analysed the medical records of 278 guinea pigs treated in four different institutions. The guinea pigs had all undergone a biochemistry panel, had their plasma concentrations measured and had a follow-up 30 days later.

The guinea pigs had been brought to the institutions for a number of reasons, including emergencies, sickness and wellness appointments. Among their diagnoses were integument disease, reproductive issues and gastrointestinal disease.

Using this data, the research team analysed the guinea pigs’ survival rates and drew comparisons to their amylase concentrations.

The analysis revealed that guinea pigs which recorded an elevated level of plasma amylase concentration (1910 to 3985 U/L) were seven times more likely to die in the next 30 days than those with a concentration within the reference intervals (1339 to 1573 U/L).

It also found increased mortality risk among guinea pigs with high blood urea nitrogen (BUN) concentrations. Guinea pigs with BUN concentrations higher 62 mg/dL had a 30 times increase in their mortality risk.

Ashley Souza and Sarah Ozawa, lead authors of the study, said: “Guinea pigs can be a challenging species to treat, especially when they enter a veterinary hospital in critical condition.

“It is our hope that this study provides further diagnostic tools for veterinarians to use when explaining options and prognosis to an owner, helping guide treatment and care for this species.”

Amylase is a digestive enzyme, which researchers say is often overlooked. Its clinical significance is largely misunderstood, however researchers now say that high amylase levels could indicate a sick guinea pig requires more diagnostic testing or supportive care.

The researchers say that, because the prognostic capacity of amylase is limited, the amylase concentration data should only be used as part of the bigger clinical picture and should not solely inform veterinary decisions.

The full study can be found in the Journal of Small Animal Practice.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.